Transcode Therapeutics Inc (RNAZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 15,661 | 19,419 | 18,634 | 6,151 | 727 |
| Operating Income | -15,661 | -19,419 | -18,634 | -6,151 | -727 |
| Interest Expense | 27 | 56 | 32 | 95 | 395 |
| Other Income | -1,068 | 928 | 1,101 | -597 | -1,223 |
| Pre-tax Income | -16,755 | -18,546 | -17,565 | -6,843 | -2,344 |
| Net Income Continuous | -16,755 | -18,546 | -17,565 | -6,843 | -2,344 |
| Net Income | $-16,755 | $-18,546 | $-17,565 | $-6,843 | $-2,344 |
| EPS Basic Total Ops | -1,320.45 | -95,770.59 | -1,000,998.00 | -0.81 | -0.51 |
| EPS Basic Continuous Ops | -1,317.91 | -95,777.74 | -1,000,995.00 | -0.81 | -0.51 |
| EPS Diluted Total Ops | -1,320.45 | -95,770.59 | -1,000,998.00 | -0.81 | -0.51 |
| EPS Diluted Continuous Ops | -1,317.91 | -95,777.74 | -1,000,995.00 | -0.81 | -0.51 |
| EPS Diluted Before Non-Recurring Items | -1,320.45 | -95,783.52 | -998,419.12 | -599,051.38 | N/A |
| EBITDA(a) | $-15,126 | $-18,902 | $-18,535 | $-6,109 | $-727 |